Condition

Neurofibromatosis Type 2 (1)

Progressive Vestibular Schwannomas (1)

Overall Status

Completed (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

University of Alabama at Birmingham (1)

Collaborator

Genentech, Inc. (1)

Intervention

bevacizumab (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

progressive vestibular schwannomas

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Neurofibromatosis Type 2, Progressive Vestibular Schwannomas Trial in United States (Bevacizumab)

Completed

Neurofibromatosis Type 2
Progressive Vestibular Schwannomas

Bevacizumab

Los Angeles, California
+11 more

Jan 26, 2021